Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House FDA Budget Bill Boosts User Fees, Trims Direct Appropriations

This article was originally published in The Tan Sheet

Executive Summary

A House Appropriations subcommittee recommends cutting FDA's fiscal 2012 direct appropriations 11.5% while increasing user fees nearly 25%.

You may also be interested in...



FDA Budget Could Face 5% Cut In Fiscal 2015

An Office of Management and Budget memo says federal agencies should reduce net discretionary spending from the initial fiscal 2015 estimate and provide options for additional cuts. Across-the-board cuts and “new user fees to offset existing spending” are not allowed in fiscal 2015 requests.

FDA Budget Could Face 5% Cut In Fiscal 2015

An Office of Management and Budget memo says federal agencies should reduce net discretionary spending from the initial fiscal 2015 estimate and provide options for additional cuts. Across-the-board cuts and “new user fees to offset existing spending” are not allowed in fiscal 2015 requests.

Senate Committee Restores FDA Funding For FY ’12

The Senate Appropriations Committee gives FDA a boost for fiscal 2012 that likely will stick, thanks to the recent debt ceiling compromise.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS105084

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel